StockData
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. (PPCB) income statement

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.76−0.12 (-6.38%)

Close on Nov 18, 2026Market cap $1.73MP/E –Yield –

See a number that looks wrong?